id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-006750-cg2i2bae	Stoots, Sarah Abramson	Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome	2019-09-06		.txt	text/plain	5220	303	31	PURPOSE OF REVIEW: Diffuse alveolar hemorrhage (DAH) is a rare but devastating manifestation of antiphospholipid syndrome (APS) patients with or without other systemic autoimmune diseases. In our experience, two different presentations of aPL-positive patients with DAH exist: (a) acute-with moderate to severe pulmonary hemorrhage (with varying degrees of respiratory failure) requiring hospitalization and (b) chronic-with mild hemoptysis, dyspnea, and/or positive imaging findings, usually seen as an outpatient. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review Difficulties in the treatment of recurring diffuse alveolar hemorrhage accompanying primary antiphospholipid syndrome: a case report and literature review Pulmonary capillaritis, alveolar hemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome Primary antiphospholipid syndrome associated with diffuse alveolar hemorrhage and pulmonary thromboembolism	./cache/cord-006750-cg2i2bae.txt	./txt/cord-006750-cg2i2bae.txt